Similar articles

• Anticardiolipin antibodies and a severe subset of systemic lupus erythematosus.

  Klemp P, Halland AM, Cooper RC. Klemp P, et al. Br J Rheumatol. 1992 Aug;31(8):567. doi: 10.1093/rheumatology/31.8.567. Br J Rheumatol. 1992. PMID: 1643457 No abstract available.
• Mesenteric thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosus.

  Cappell MS, Seibold JR. Cappell MS, et al. Am J Gastroenterol. 1992 Apr;87(4):520-2. Am J Gastroenterol. 1992. PMID: 1553941
• Prevalence & clinical associations of anticardiolipin antibodies in patients with systemic lupus erythematosus in India.

  Saluja S, Kumar A, Khamashta M, Hughes GR, Malaviya AN. Saluja S, et al. Indian J Med Res. 1990 Aug;92:224-7. Indian J Med Res. 1990. PMID: 2228065
• Lack of association between anticardiolipin antibodies and heart valve disease in Chinese patients with systemic lupus erythematosus.

  Li EK, Crozier IG, Milne MJ, Nicholls MG, Cohen MG. Li EK, et al. Lancet. 1990 Aug 25;336(8713):504-5. doi: 10.1016/0140-6736(90)92052-j. Lancet. 1990. PMID: 1975008 No abstract available.
• [The role of anticardiolipin antibodies in the pathogenesis of arterial and venous thromboses].

  Eber B. Eber B. Acta Med Austriaca. 1990;17(4):67-70. Acta Med Austriaca. 1990. PMID: 2291381 Review. German.